272BIO Limited is an animal health antibody discovery company.  Our strategy is to discover and develop highly innovative, afforable antibody therapeutics to treat companion animals and livestock. 

272BIO Limited is a R&D company with run by a team of experienced antibody drug discovery experts looking to transform the animal health medicines market.

Biotechnology

Therapeutics

Veterinary & Pet

272BIO Limited

272BIO Limited's headquarters in Pirbright, United Kingdom

The Ghent office specializes in CMC research, focusing on the development and manufacturing of biopharmaceuticals.

Ghent

Charles Owen

Liz Littlewood

Tom Hayward

This department conducts scientific investigations and experiments to advance knowledge and innovation.

Research Science

This department conducts advanced research to drive innovation and discovery in various scientific fields.

Scientific Research

This department focuses on the research and development of biotechnological solutions, including antibody engineering and CMC processes.

Biotechnology Research

This department oversees operational efficiency and financial management to drive organizational performance.

Operations and Finance

This department focuses on scientific inquiry and innovation to develop new products and technologies.

Research and Development

This department conducts investigations and analyzes data to support scientific advancements and product development.

272BIO Limited

Org chart

Teams

Research Science

Scientific Research

Biotechnology Research

Operations and Finance

Research and Development

Research Division

Offices

272BIO Limited

Org chart

Teams

Research Science

Scientific Research

Biotechnology Research

Operations and Finance

Research and Development

Research Division

Offices

Related companies